|
|
|
Abbott Laboratories Highlights Stent Test Results
Abbott Laboratories says results of a large study put its artery-opening stent on equal footing with a stent made by a competitor in a difficult-to-treat group of patients.
|
|
0 Comments 
WASHINGTON (September 23, 2009)--Abbott Laboratories said Tuesday results of a large study put its artery-opening Xience stent on equal footing with competitor Boston Scientific in diabetics, a difficult-to-treat group of patients.
Abbott said there was no difference in safety complications between diabetic patients with a Xience drug-coated stent, compared to Boston Scientific's Taxus Express stent.
Previous results had suggested fewer heart-related problems with Taxus, helping Boston Scientific protect its share of the market for the mesh-wire tubes.
Stents are used to prop open arteries after they have been surgically cleared of fatty plaque.
Boston Scientific complains Abbott compared Xience to Taxus Express, which has been replaced by the more advanced Taxus Liberte.
 |
Double
Dollar Deals Half Price Deals at Central Texas restaurants and businesses. A new deal every Thursday at 7:00am. |
 |
Boss
of the Month Who is Central Texas’ best boss? Nominate your supervisor for Boss of the Month! |
 |
Golden
Apple Your chance to nominate an outstanding teacher. Find out how they are making a difference in classrooms. |
 |
Emily Wants to Know Emily Matthews' inquisitive look at life in Central Texas. |
 |
Army Way Learn all about the symbols, traditions, and customs of the US Army. |
